Cargando…

Vedolizumab-Associated Hypereosinophilia and Hepatoxicity

Vedolizumab, which is approved for the treatment of ulcerative colitis, has been associated with drug-induced liver injury because of an unclear mechanism. We describe the case of a 29-year-old man who presented with abnormal liver enzymes and peripheral hypereosinophilia after vedolizumab initiatio...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Davide, Bessissow, Talat, Marcus, Victoria, Benmassaoud, Amine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668547/
https://www.ncbi.nlm.nih.gov/pubmed/36404891
http://dx.doi.org/10.14309/crj.0000000000000905

Ejemplares similares